Skip to content
  • info@kerentech.com
  • +972542570243
Linkedin-in
  • About Us
  • Our Expertise
  • News
  • Publications
  • Contact Us
Menu
  • About Us
  • Our Expertise
  • News
  • Publications
  • Contact Us

News

Cell and Life Therapeutics announces that Prof.Ankur Jain in MIT Biology Dept., joins the Company as CSO and the opening of its US company.

Read More »
October 27, 2022

EmstoPA has received the Regulatory Endorsement of Development Program by British MHRA

Read More »
October 27, 2022

Our client BrainEver Receives FDA Orphan Drug Designation for BREN-02, (human recombinant Engrailed 1) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Read More »
October 13, 2022

Protected: C&L Video

Read More »
December 17, 2020

Our client Goodgut signs an agreement with Palex to launch first non-invasive diagnostic tests for IBS and IBD

Read More »
May 22, 2019

Our client Abac Therapeutics raises $16M

Read More »
February 19, 2018

Our client Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP

Read More »
August 2, 2017

Kerentech participates at “Transferencia de tecnología y mejora de las redes de cooperación”, Santiago de Compostela, Spain

Read More »
October 3, 2013

Kerentech participates at Bioinvestor Day Galicia 2013

Read More »
October 3, 2013
  • About Us
  • Our Expertise
  • News
  • Publications
  • Contact Us
  • About Us
  • Our Expertise
  • News
  • Publications
  • Contact Us
  • info@kerentech.com
  • +972542570243
  • 19, Ha Lamed Hey St, Jerusalem, Israel
Linkedin-in

© 2024 Kerentech All Rights Reserved.

Whatsapp